Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era
Andrew Johnsrud, Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood, Judith A. Shizuru, Laura Johnston, Sally Arai, Wen‐Kai Weng, Robert Lowsky, Andrew R. Rezvani, Everett Meyer, Matthew J. Frank, Robert S. Negrin, David B. Miklos, Surbhi Sidana
Topics & Concepts
PlerixaforMedicineLenalidomideMultiple myelomaGranulocyte colony-stimulating factorCyclophosphamideApheresisChemotherapySurgeryMobilizationUrologyInternal medicineOncologyGastroenterologyCXCR4PlateletReceptorChemokineArchaeologyHistoryMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationImmunotherapy and Immune Responses